Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Aurora Spine Corporation
  6. News
  7. Most relevant
    ASG   CA05206X1087

AURORA SPINE CORPORATION

(ASG)
  Report
Delayed Bourse de Toronto  -  11:56:12 2023-02-02 am EST
0.4400 CAD   -2.22%
2022Transcript : Aurora Spine Corporation, Q3 2022 Earnings Call, Nov 21, 2022
CI
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about AURORA SPINE CORPORATION
2022Transcript : Aurora Spine Corporation, Q3 2022 Earnings Call, Nov 21, 2022
CI
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months..
CI
2022Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial ..
GL
2022Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial ..
GL
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using Z..
AQ
2022Aurora Spine Corp Announced Positive Interim Results from Clinical Study
MT
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study Using Z..
CI
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using Z..
GL
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using Z..
AQ
2022Aurora Spine Corp Receives 2022 Best New Spine Technology Award; to Attend North Americ..
MT
2022Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeti..
GL
2022Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeti..
AQ
2022Aurora Spine Corporation Showcasing Its Product Line At North American Spine Society An..
CI
2022Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-ma..
GL
2022Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-ma..
AQ
2022Aurora Spine Corp Brief: Announcing FDA 510(k) Clearance for its..
MT
2022Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sac..
GL
2022Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sac..
AQ
2022Aurora Spine Corporation Announces FDA 510(K) Clearance for Its Silo TFX MIS Sacroiliac..
CI
2022Aurora Spine Corp Announces FDA 510(k) Clearance For Sacroiliac Joint Fixation System
MT
2022Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sac..
GL
2022Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sac..
GL
2022Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Confe..
GL
2022Aurora Spine Q2 Net Loss Narrows, Revenue Jumps Near 68%
MT
2022Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
AQ
2022Aurora Spine Corporation Reports Earnings Results for the Second Quarter Ended June 30,..
CI
2022Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial..
GL
2022Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial..
AQ
2022Aurora's Spinal Fusion Device Gets FDA Clearance For Lumbar Spinal Stenosis Indication
MT
2022Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its Z..
GL
2022Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its Z..
AQ
2022Aurora Spine Announces New FDA Indication Clearance of Lumbar Spinal Stenosis for Its Z..
CI
2022Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Tec..
GL
2022Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Tec..
AQ
2022Aurora Spine Corporation Higher As Receives FDA 510(k) Clearance for Dexa Solo-L Spinal..
MT
2022Aurora Spine Corporation Receives FDA 510(K) Clearance for Its Dexa Solo-LTM Spinal Fus..
CI
2022Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumba..
GL
2022Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumba..
AQ
2022Aurora Spine : Management Discussion and Analysis
PU
2022Aurora Spine Reports Q1 Net Loss of US$0.01 Per Share, Record Revenue of US$3.55 Millio..
MT
2022Aurora Spine Corporation Reports Earnings Results for the First Quarter Ended March 31,..
CI
2022Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial..
GL
2022Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial..
AQ
2022Correction : Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial R..
GL
2022Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
GL
2022Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
GL
2022Aurora Spine Corporation Reports Earnings Results for the Full Year Ended December 31, ..
CI
2022Aurora Spine Corporation Schedules Release for Fourth Quarter and Fiscal Year 2021 Fina..
GL
2022Aurora Spine Corporation to Participate in the Lytham Partners Spring 2022 Investor Con..
GL
2022Aurora Spine Corp Says Initial Implantation of World's First Bone Density Matched DEXA-..
MT
2022Aurora Spine Corporation Announces Initial Implantation of the First Bone Density Match..
CI
2022Aurora Spine Corporation Announces Initial Implantation of the World's First Bone Densi..
GL
2022Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Ec..
AQ
2022Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Ec..
CI
2022Aurora Spine Corporation Provides Revenue Guidance for Fourth Quarter and Full Year 202..
CI
2022Aurora Spine Corporation Announces Preliminary Revenue for Fourth Quarter and Fiscal 20..
AQ
2022Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant f..
GL
2022Aurora Spine Corporation Receives Notice of Allowance for Patent for Spinal Implant for..
CI
2022Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate
AQ
2022Aurora Spine Corporation Completes First Anterior Cervical Discectomy and Fusion Proced..
CI
2021Aurora Spine Corp on Need For "Bone Mineral Density-Matched Interbody Cage", Comments o..
MT
2021Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Den..
AQ
2021Aurora Spine Corporation Announces Newly Published Paper on Need for A Bone Mineral Den..
CI
2021Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Con..
AQ
2021Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprieta..
AQ
2021Aurora Spine Reports Q3 Net Loss of US$0.37 Million
MT
2021Aurora Spine Corporation Announces Third Quarter 2021 Financial Results
GL
2021Aurora Spine Corporation Provides Earnings Guidance for the Year 2021
CI
2021Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months..
CI
2021Aurora Spine Corporation Schedules Release for Third Quarter 2021 Financial Results and..
GL
1  2  3  4Next
Upcoming event on AURORA SPINE CORPORATION